CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Nashville, Tennessee, United States and 9 other locations
The central hypothesis is that inflammation mediators are biomarkers of both systemic diabetes and Diabetic Retinopathy (DR) progre...
Phase 1
Nashville, Tennessee, United States
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Nashville, Tennessee, United States and 40 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
Nashville, Tennessee, United States and 96 other locations
in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...
Phase 3
Nashville, Tennessee, United States and 70 other locations
study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...
Phase 3
Goodlettsville, Tennessee, United States and 182 other locations
This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in p...
Phase 3
Nashville, Tennessee, United States and 73 other locations
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
Nashville, Tennessee, United States and 29 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Nashville, Tennessee, United States and 228 other locations
the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...
Nashville, Tennessee, United States and 28 other locations
Clinical trials
Research sites
Resources
Legal